Question 1

Has Adrienne Keener, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $4,916 in general payments to Adrienne Keener, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Adrienne Keener, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Adrienne Keener, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	6	$4,446
Medtronic(2 entities)	2	$226
Neurocrine Biosciences, Inc.	1	$131
Merz North America, Inc.	2	$69
Abbott	1	$24
Acorda Therapeutics, Inc	1	$19
Travere Therapeutics, Inc.	2	$1

Drug	Claims	Cost to plans & patients
AustedoDeutetrabenazine	12	$140,131
RytaryCarbidopa/Levodopa	21	$30,870
Rasagiline Mesylate	32	$6,652
Pramipexole ErPramipexole Di-Hcl	14	$6,341
Carbidopa-LevodopaCarbidopa/Levodopa	117	$6,101
Ropinirole ErRopinirole Hcl	19	$5,577
Carbidopa-Levodopa ErCarbidopa/Levodopa	58	$3,867
Entacapone	19	$2,045
Selegiline Hcl	14	$834
Gabapentin	25	$481
Donepezil Hcl	28	$233
Escitalopram Oxalate	19	$123

Adrienne Keener, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other neurology in Los Angeles